

The prevalence of alcohol use disorder (AUD) and alcohol-associated liver disease (ALD) is rising. The National Institute on Alcohol Abuse and Alcoholism organised a multistakeholder workshop focused on reducing the burden of ALD. Decreasing ALD morbidity and mortality requires a multipronged approach, including increased population-based screening for AUD, early recognition of ALD, and multidisciplinary treatment. Recommended screening tools for alcohol use include the alcohol use disorders identification test for consumption (AUDIT-C).
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet
Gastroenterology & Hepatology
|15th Jan, 2026
|The Lancet